AlphaHelix Molecular Diagnostics AB (publ) (ALPH.ST)
- Previous Close
0.2720 - Open
0.3380 - Bid 0.2860 x --
- Ask 0.3380 x --
- Day's Range
0.2820 - 0.3380 - 52 Week Range
0.1990 - 0.7900 - Volume
6,631 - Avg. Volume
38,613 - Market Cap (intraday)
21.429M - Beta (5Y Monthly) 0.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AlphaHelix Molecular Diagnostics AB (publ) designs, develops, and distributes diagnostics products in the Nordic region and internationally. The company distributes equipment; consumables and reagents for molecular biology; and research and diagnostic products in Sweden and the Nordics. It also develops, produces, and sells products for genetic fetal diagnostics, as well as genetic miscarriage and infertility diagnostics products. In addition, the company engages in the development of products for congenital heart defect. Its product portfolio includes Rob, an automated 96/384 qPCR setup; BugScreener, a system for screening methicillin resistant staphylococcus aures; and aAmp, a thermal cycler that utilizes SuperConvection technology, which enables accurate PCR assays. The company was incorporated in 1998 and is headquartered in Stockholm, Sweden.
www.alphahelix.com13
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: ALPH.ST
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALPH.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALPH.ST
Valuation Measures
Market Cap
21.43M
Enterprise Value
18.91M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.82
Price/Book (mrq)
2.06
Enterprise Value/Revenue
0.72
Enterprise Value/EBITDA
-2.52
Financial Highlights
Profitability and Income Statement
Profit Margin
-36.31%
Return on Assets (ttm)
-25.40%
Return on Equity (ttm)
-62.54%
Revenue (ttm)
26.1M
Net Income Avi to Common (ttm)
-9.48M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
3.63M
Total Debt/Equity (mrq)
10.63%
Levered Free Cash Flow (ttm)
-1.87M